A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder

@article{Werling2007ACO,
  title={A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder},
  author={Linda L. Werling and Ashleigh B. Keller and J Gonzalez Frank and Samer J. Nuwayhid},
  journal={Experimental Neurology},
  year={2007},
  volume={207},
  pages={248-257}
}
We compared the binding profiles of medications potentially useful in the treatment of involuntary emotional expression disorder at twenty-six binding sites in rat brain tissue membranes. Sites were chosen based on likelihood of being target sites for the mechanism of action of the agents in treating the disorder or their likelihood in producing side effects experienced by patients treated with psychoactive agents. We used radioligand binding assays employing the most selective labeled ligands… 
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
TLDR
Data suggest that dextromethorphan exerts some of its antidepressant actions through σ1 receptors, which has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities to the N-methyl-D-aspartate receptor antagonist ketamine.
Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats
TLDR
The present findings provide additional support for antidepressant effects produced by dextromethorphan using a differential reinforcement of low-rate 72-s schedule in male and female rats.
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.
TLDR
The findings suggest that DM/Q likely inhibits serotonin and norepinephrine reuptake and also blocks NMDA receptors with rapid kinetics, and may also antagonize nicotinic acetylcholine receptors, particularly those composed of α3β4 subunits, and cause agonist activity at sigma-1 receptors.
Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
Although reports of dextromethorphan (DXM) abuse have increased recently, few studies have examined the effects of high doses of DXM. This study in humans evaluated the effects of supratherapeutic
The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry
TLDR
The effects of chronic 2-week exposure to 10 and 50 μg/L amitriptyline on zebrafish behavior and monoamine neurotransmitters are examined to support the utility of this organism as an in-vivo model for CNS drug screening.
Dextromethorphan as a potential rapid-acting antidepressant.
TLDR
It is hypothesized that dextromethorphan may have antidepressant efficacy in bipolar, unipolar, major depression, psychotic, and treatment-resistant depressive disorders, and may display rapid-onset of antidepressant response.
Receptor targets for antidepressant therapy in bipolar disorder: an overview.
TLDR
A complete and systematic review of agents with definite positive or negative results concerning efficacy and pharmacodynamic properties suggests that the stronger predictors for antidepressant efficacy in bipolar depression were norepinephrine alpha-1, dopamine D1 and histamine antagonism, followed by 5-HT2A, muscarinic and dopamine D2 and D3 antagonism and eventually by norpinephrine reuptake inhibition and 5HT-1A agonism.
A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers
TLDR
Minimal pharmacokinetic and pharmacodynamic interactions were observed between memantine and DMQ, suggesting they can be coadministered without dose adjustment.
Characterization of pulmonary sigma receptors by radioligand binding.
TLDR
The expression of appreciable populations of sites on mouse lung membranes that exhibit radioligand binding properties and pharmacology consistent with assignment as sigma1 and sigma2 receptors are established and provides a foundation for studies of drug interactions with pulmonary sigma 1 and s Sigma2 receptors in vitro and in vivo.
Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.
TLDR
A phase IIa open label clinical trial examining the efficacy and tolerability of a combination of dextromethorphan and the CYP2D6 enzyme inhibitor quinidine in patients with treatment-resistant depression reports acceptable tolerability and preliminary efficacy of DM/Q up to 45/10mg administered every 12h in Patients with TRD.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 60 REFERENCES
An autoradiographic study of dextromethorphan high‐affinity binding sites in rat brain: sodium‐dependency and colocalization with paroxetine
TLDR
It is suggested that dextromethorphan might interact, in the presence of sodium, with the 5‐HT uptake mechanism in rat brain, and paroxetine and dextromeethorphans mutually displaced their binding at concentrations in the low nanomolar range.
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
TLDR
Using radioligand binding assays, the equilibrium dissociation constants (KD's) for 37 antidepressants, three of their metabolites, some mood stabilizers, and assorted other compounds for the human serotonin, norepinephrine, and dopamine transporters are determined to help predict some possible adverse effects and drug-drug interactions of antidepressants and related compounds.
Dextromethorphan and sigma ligands: common sites but diverse effects.
TLDR
The current version of the "sigma receptor", with high affinity for the dextrorotatory sigma opiates, cannot explain the psychotomimetic effects of the levorotatory enantiomers.
Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan
Dextromethorphan ((+)-3-methoxy-N-methylmorphinan, DM) has been shown to have both anticonvulsant and neuroprotective effects. The mechanisms of these CNS effects of DM have been suggested to be
[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
  • S. Tejani-Butt
  • Biology, Medicine
    The Journal of pharmacology and experimental therapeutics
  • 1992
TLDR
[3H]Nisoxetine should prove to be a useful tool to study the regulation of uptake sites for NE as well as a useful marker for noradrenergic innervation in the study of various neurological diseases.
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression
TLDR
Citalopram produced a mixed anxiogenic-/anxiolyticlike response in rats tested in the two-compartment black and white box and ritanserin potentiated the antiaggressive effect of 1,5-HTP as well as that of 8-OH-DPAT.
Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man
TLDR
Serum and CSF levels were correlated to the daily dose, but not to the duration of treatment, and memantine is expected to specifically interact with the PCP binding site of the NMDA receptor.
Pharmacology of antidepressants--characteristics of the ideal drug.
TLDR
The newer second- generation antidepressants have distinct pharmacologic advantages in comparison with the tricyclic antidepressants and the older second-generation compounds.
Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers
TLDR
Results from both studies indicated that 25 to 30 mg Q is adequate to maximally suppress O‐demethylation of DM, with no difference between extensive and poor metabolizer phenotypes.
Heterogeneity of mammalian α2-adrenoceptors delineated by [3H]yohimbine binding
TLDR
Yohimbine binding to membrane preparations of human colon, cerebral cortex, kidney, spleen and platelets was compared with binding to preparations of animal tissues, suggesting that human α2-adrenoceptors differ in a number of ways from those present in tissues from the other mammalian species examined.
...
1
2
3
4
5
...